Cargando…
rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application
Over the last decade, pioneering molecular gene therapy for inner-ear disorders have achieved experimental hearing improvements after a single local or systemic injection of adeno-associated, virus-derived vectors (rAAV for recombinant AAV) encoding an extra copy of a normal gene, or ribozymes used...
Autores principales: | Blanc, Fabian, Mondain, Michel, Bemelmans, Alexis-Pierre, Affortit, Corentin, Puel, Jean-Luc, Wang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073754/ https://www.ncbi.nlm.nih.gov/pubmed/32098144 http://dx.doi.org/10.3390/jcm9020589 |
Ejemplares similares
-
A Single Cisterna Magna Injection of AAV Leads to Binaural Transduction in Mice
por: Blanc, Fabian, et al.
Publicado: (2022) -
Intravenous rAAV2/9 injection for murine cochlear gene delivery
por: Shibata, Seiji B., et al.
Publicado: (2017) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013) -
rAAV8 and rAAV9-Mediated Long-Term Muscle Transduction with Tacrolimus (FK506) in Non-Human Primates
por: Ishii, Akiko, et al.
Publicado: (2020) -
rAAV Manufacturing: The Challenges of Soft Sensing during Upstream Processing
por: Iglesias, Cristovão Freitas, et al.
Publicado: (2023)